Company intelligence / Profile preview

BiomeHub

Florianópolis, Santa Catarina, Brazilbiome-hub.com ↗

Ownership: Private
Development stage: Commercial

Overview

BiomeHub provides advanced molecular tests for the identification and analysis of bacteria in the intestine, vagina, and oral cavity. Their products are used by healthcare professionals to diagnose dysbiosis and guide precision nutrition/medicine strategies. The company’s solutions are commercially available in Brazil

Therapeutic areas: GastroenterologyWomen's HealthInfectious DiseasesOther
Modalities: Live biotherapeutic product therapyMicrobial therapyMolecular diagnostics
Industry: Molecular Diagnostics

Partnerships

Eretz.Bio (investor/incubator partnership)

Beyond the preview

Go deeper on BiomeHub.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BiomeHub.

Explore the full profile